Therefore, this event may represent one of the driving forces for early-stage breast tumor cells to undergo EMT and subsequent metastatic progression, thus highlighting the role of PTPN18 as a potential target for early therapeutic intervention in breast cancer progression. This evidence concerns the gene PTPN18 and breast cancer.